Literature DB >> 4729051

Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.

W E Shell, J F Lavelle, J W Covell, B E Sobel.   

Abstract

To estimate the ultimate extent of myocardial damage during evolving myocardial infarction in conscious dogs and patients, we analyzed early serum creatine phosphokinase (CPK) changes with nonlinear curve-fitting techniques. In experiments with dogs, serial serum CPK changes were fit to a log-normal function by the least squares method; the extent of the completed infarct was calculated by analysis of observed serum CPK changes and verified by measurement of myocardial CPK depletion 24 h after coronary occlusion. Early prediction of myocardial damage was based on projected serum CPK values from best fit curves based on data obtained during the first 5 h after initial elevation of enzyme activity. The correlation between predicted and observed values was close (r > 0.96, n = 11). In 11 additional conscious animals subjected to coronary occlusion, isoproterenol was administered continuously as soon as damage had been estimated from projected serum CPK values. The extent of the completed infarct was assessed by analysis of all serial serum CPK values and verified by analysis of myocardial CPK depletion 24 h after coronary occlusion. In each experiment the calculated completed infarct size exceeded infarct size projected before administration of isoproterenol (average increase = 44+/-10 [SE]%). When similar calculations were applied in experiments with eight dogs treated with propranolol, myocardial salvage was detected in 50% of the animals. In 30 patients with uncomplicated acute myocardial infarction the extent of the completed infarct, measured by analysis of CPK activity in serum samples obtained every 2 h, was compared with damage estimated from CPK values projected by the best fit log-normal curve derived from data obtained during the first 7 h after the initial serum CPK elevation. The estimate of damage based on early data correlated closely with the extent of infarction calculated from all available serial serum CPK values (r = 0.93, n = 30). Thus, the extent of the completed infarct could be estimated accurately during the early evolution of infarction. In patients with spontaneous extension of infarction manifested by chest pain and electrocardiographic changes, the calculated extent of the completed infarct exceeded that predicted. Conversely, salvage of myocardium, after reduction of myocardial oxygen requirements by administration of trimethaphan, was reflected by reduction of the extent of the calculated completed infarct with respect to that predicted from early serum CPK changes.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729051      PMCID: PMC302518          DOI: 10.1172/JCI107450

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  A METHOD FOR THE QUANTITATION OF MYOCARDIAL INFARCTS AND THE RELATION OF SERUM ENZYME LEVELS TO INFARCT SIZE.

Authors:  M M NACHLAS; M M FRIEDMAN; S P COHEN
Journal:  Surgery       Date:  1964-05       Impact factor: 3.982

2.  Serum transaminase levels in experimental myocardial infarction.

Authors:  C M AGRESS; H I JACOBS; H F GLASSNER; M A LEDERER; W G CLARK; F WROBLEWSKI; A KARMEN; J S LADUE
Journal:  Circulation       Date:  1955-05       Impact factor: 29.690

3.  Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity.

Authors:  M M NACHLAS; T K SHNITKA
Journal:  Am J Pathol       Date:  1963-04       Impact factor: 4.307

4.  Transaminase in experimental myocardial infarction.

Authors:  J LEMLEY-STONE; J M MERRILL; J T GRACE; G R MENEELY
Journal:  Am J Physiol       Date:  1955-12

5.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.

Authors:  P R Maroko; P Libby; J W Covell; B E Sobel; J Ross; E Braunwald
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

6.  Myocardial changes associated with cardiogenic shock.

Authors:  D L Page; J B Caulfield; J A Kastor; R W DeSanctis; C A Sanders
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

7.  Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.

Authors:  P R Maroko; P Libby; B E Sobel; C M Bloor; H D Sybers; W E Shell; J W Covell; E Braunwald
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

9.  Quantitative study of infarcted myocardium in cardiogenic shock.

Authors:  C Harnarayan; M A Bennett; B L Pentecost; D B Brewer
Journal:  Br Heart J       Date:  1970-11

10.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

View more
  25 in total

1.  Influence of increased circulating levels of splanchnic lysosomal enzymes on the response to myocardial ischemia.

Authors:  J A Spath; E A Reed; A M Lefer
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

Review 2.  Non-invasive assessment of the effects of drugs on acute myocardial infarct size in man.

Authors:  D Maclean
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

3.  Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction.

Authors:  M K Heng; R M Norris; B N Singh; C Barratt-Boyes
Journal:  Br Heart J       Date:  1977-07

4.  Comparison of haemodynamic effects of phentolamine, sodium nitroprusside, and glyceryl trinitrate in acute myocardial infarction.

Authors:  V Kötter; E R von Leitner; J Wunderlich; R Schröder
Journal:  Br Heart J       Date:  1977-11

Review 5.  Myocardial infarction size: measurement and modification.

Authors:  J A Cairns
Journal:  Can Med Assoc J       Date:  1977-08-06       Impact factor: 8.262

6.  Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants.

Authors:  A K M Tarikuz Zaman; Satoshi Fujii; David J Schneider; Douglas J Taatjes; H Roger Lijnen; Burton E Sobel
Journal:  Histochem Cell Biol       Date:  2007-06-19       Impact factor: 4.304

Review 7.  Creatine kinase in the dog: a review.

Authors:  M Aktas; D Auguste; H P Lefebvre; P L Toutain; J P Braun
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

8.  Effect of propranolol on enzymatic and histochemical estimates of infarct size in experimental myocardial infarction.

Authors:  G J Jesmok; D C Warltier; G J Gross; H F Hardman
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

9.  Chest pain in the early recognition of large infarcts.

Authors:  J R Ledwich
Journal:  Can Med Assoc J       Date:  1977-01-08       Impact factor: 8.262

10.  Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.

Authors:  D Maclean; M C Fishbein; E Braunwald; P R Maroko
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.